{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T09:35:48Z","timestamp":1792056948867,"version":"4.4.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T00:00:00Z","timestamp":1417996800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1038\/nm.3770","type":"journal-article","created":{"date-parts":[[2014,12,8]],"date-time":"2014-12-08T12:52:43Z","timestamp":1418043163000},"page":"47-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":319,"title":["The Ashwell-Morell receptor regulates hepatic thrombopoietin production via JAK2-STAT3 signaling"],"prefix":"10.1038","volume":"21","author":[{"given":"Renata","family":"Grozovsky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonija Jurak","family":"Begonja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaifeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Visner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0788-9204","authenticated-orcid":false,"given":"Herv\u00e9","family":"Falet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin M","family":"Hoffmeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,8]]},"reference":[{"key":"BFnm3770_CR1","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.1172\/JCI26674","volume":"115","author":"K Kaushansky","year":"2005","unstructured":"Kaushansky, K. The molecular mechanisms that control thrombopoiesis. J. Clin. Invest. 115, 3339\u20133347 (2005).","journal-title":"J. Clin. Invest."},{"key":"BFnm3770_CR2","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1182\/asheducation-2009.1.147","volume":"2009","author":"K Kaushansky","year":"2009","unstructured":"Kaushansky, K. Determinants of platelet number and regulation of thrombopoiesis. Hematology (Am. Soc. Hematol. Educ. Program) 2009, 147\u2013152 (2009).","journal-title":"Hematology (Am. Soc. Hematol. Educ. Program)"},{"key":"BFnm3770_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1146\/annurev.med.60.042307.181154","volume":"60","author":"DJ Kuter","year":"2009","unstructured":"Kuter, D.J. Thrombopoietin and thrombopoietin mimetics in the treatment of thrombocytopenia. Annu. Rev. Med. 60, 193\u2013206 (2009).","journal-title":"Annu. Rev. Med."},{"key":"BFnm3770_CR4","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1182\/blood.V85.10.2720.bloodjournal85102720","volume":"85","author":"DJ Kuter","year":"1995","unstructured":"Kuter, D.J. & Rosenberg, R.D. The reciprocal relationship of thrombopoietin (Mpl ligand) to changes in the platelet mass during busulfan-induced thrombocytopenia in the rabbit. Blood 85, 2720\u20132730 (1995).","journal-title":"Blood"},{"key":"BFnm3770_CR5","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood.V88.7.2578.bloodjournal8872578","volume":"88","author":"K Cohen-Solal","year":"1996","unstructured":"Cohen-Solal, K. et al. Constitutive expression of Mpl ligand transcripts during thrombocytopenia or thrombocytosis. Blood 88, 2578\u20132584 (1996).","journal-title":"Blood"},{"key":"BFnm3770_CR6","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1182\/blood.V87.6.2154.bloodjournal8762154","volume":"87","author":"PJ Fielder","year":"1996","unstructured":"Fielder, P.J. et al. Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets. Blood 87, 2154\u20132161 (1996).","journal-title":"Blood"},{"key":"BFnm3770_CR7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1038\/sj.leu.2400946","volume":"12","author":"K Shinjo","year":"1998","unstructured":"Shinjo, K. et al. Serum thrombopoietin levels in patients correlate inversely with platelet counts during chemotherapy-induced thrombocytopenia. Leukemia 12, 295\u2013300 (1998).","journal-title":"Leukemia"},{"key":"BFnm3770_CR8","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1046\/j.1365-2141.1999.01459.x","volume":"105","author":"C Engel","year":"1999","unstructured":"Engel, C., Loeffler, M., Franke, H. & Schmitz, S. Endogenous thrombopoietin serum levels during multicycle chemotherapy. Br. J. Haematol. 105, 832\u2013838 (1999).","journal-title":"Br. J. Haematol."},{"key":"BFnm3770_CR9","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1182\/blood.V86.10.3668.bloodjournal86103668","volume":"86","author":"JM McCarty","year":"1995","unstructured":"McCarty, J.M., Sprugel, K., Fox, N., Sabath, D. & Kaushansky, K. Murine thrombopoietin mRNA levels are modulated by platelet count. Blood 86, 3668\u20133675 (1995).","journal-title":"Blood"},{"key":"BFnm3770_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1182\/blood.V89.1.101","volume":"89","author":"R Sungaran","year":"1997","unstructured":"Sungaran, R., Markovic, B. & Chong, B. Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization. Blood 89, 101\u2013107 (1997).","journal-title":"Blood"},{"key":"BFnm3770_CR11","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1182\/blood.V92.6.2189","volume":"92","author":"S Qian","year":"1998","unstructured":"Qian, S., Fu, F., Li, W., Chen, Q. & de Sauvage, F. Primary role of the liver in thrombopoietin production shown by tissue-specific knockout. Blood 92, 2189\u20132191 (1998).","journal-title":"Blood"},{"key":"BFnm3770_CR12","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1055\/s-0037-1616745","volume":"86","author":"EM Wolber","year":"2001","unstructured":"Wolber, E.M., Fandrey, J., Frackowski, U. & Jelkmann, W. Hepatic thrombopoietin mRNA is increased in acute inflammation. Thromb. Haemost. 86, 1421\u20131424 (2001).","journal-title":"Thromb. Haemost."},{"key":"BFnm3770_CR13","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.exphem.2008.02.012","volume":"36","author":"B McIntosh","year":"2008","unstructured":"McIntosh, B. & Kaushansky, K. Transcriptional regulation of bone marrow thrombopoietin by platelet proteins. Exp. Hematol. 36, 799\u2013806 (2008).","journal-title":"Exp. Hematol."},{"key":"BFnm3770_CR14","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1089\/10799900050023915","volume":"20","author":"EM Wolber","year":"2000","unstructured":"Wolber, E.M. & Jelkmann, W. Interleukin-6 increases thrombopoietin production in human hepatoma cells HepG2 and Hep3B. J. Interferon Cytokine Res. 20, 499\u2013506 (2000).","journal-title":"J. Interferon Cytokine Res."},{"key":"BFnm3770_CR15","doi-asserted-by":"publisher","first-page":"2720","DOI":"10.1182\/blood.V98.9.2720","volume":"98","author":"A Kaser","year":"2001","unstructured":"Kaser, A. et al. Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis. Blood 98, 2720\u20132725 (2001).","journal-title":"Blood"},{"key":"BFnm3770_CR16","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1056\/NEJMoa1110352","volume":"366","author":"RL Stone","year":"2012","unstructured":"Stone, R.L. et al. Paraneoplastic thrombocytosis in ovarian cancer. N. Engl. J. Med. 366, 610\u2013618 (2012).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3770_CR17","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.transci.2009.10.008","volume":"42","author":"V Rumjantseva","year":"2010","unstructured":"Rumjantseva, V. & Hoffmeister, K.M. Novel and unexpected clearance mechanisms for cold platelets. Transfus. Apher. Sci. 42, 63\u201370 (2010).","journal-title":"Transfus. Apher. Sci."},{"issue":"suppl. 1","key":"BFnm3770_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1111\/j.1538-7836.2011.04276.x","volume":"9","author":"KM Hoffmeister","year":"2011","unstructured":"Hoffmeister, K.M. The role of lectins and glycans in platelet clearance. J. Thromb. Haemost. 9 (suppl. 1), 35\u201343 (2011).","journal-title":"J. Thromb. Haemost."},{"key":"BFnm3770_CR19","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/nm.2030","volume":"15","author":"V Rumjantseva","year":"2009","unstructured":"Rumjantseva, V. et al. Dual roles for hepatic lectin receptors in the clearance of chilled platelets. Nat. Med. 15, 1273\u20131280 (2009).","journal-title":"Nat. Med."},{"key":"BFnm3770_CR20","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1182\/blood-2009-01-199414","volume":"114","author":"AL S\u00f8rensen","year":"2009","unstructured":"S\u00f8rensen, A.L. et al. Role of sialic acid for platelet life span: exposure of \u03b2-galactose results in the rapid clearance of platelets from the circulation by asialoglycoprotein receptor\u2013expressing liver macrophages and hepatocytes. Blood 114, 1645\u20131654 (2009).","journal-title":"Blood"},{"key":"BFnm3770_CR21","doi-asserted-by":"publisher","first-page":"20218","DOI":"10.1073\/pnas.1313905110","volume":"110","author":"PK Grewal","year":"2013","unstructured":"Grewal, P.K. et al. Inducing host protection in pneumococcal sepsis by preactivation of the Ashwell-Morell receptor. Proc. Natl. Acad. Sci. USA 110, 20218\u201320223 (2013).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3770_CR22","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/nm1760","volume":"14","author":"PK Grewal","year":"2008","unstructured":"Grewal, P.K. et al. The Ashwell receptor mitigates the lethal coagulopathy of sepsis. Nat. Med. 14, 648\u2013655 (2008).","journal-title":"Nat. Med."},{"key":"BFnm3770_CR23","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0076-6879(10)79013-3","volume":"479","author":"PK Grewal","year":"2010","unstructured":"Grewal, P.K. The Ashwell-Morell receptor. Methods Enzymol. 479, 223\u2013241 (2010).","journal-title":"Methods Enzymol."},{"key":"BFnm3770_CR24","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1182\/blood-2008-03-077966","volume":"112","author":"RL Levine","year":"2008","unstructured":"Levine, R.L. & Gilliland, D.G. Myeloproliferative disorders. Blood 112, 2190\u20132198 (2008).","journal-title":"Blood"},{"key":"BFnm3770_CR25","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/j.tips.2012.08.005","volume":"33","author":"LM LaFave","year":"2012","unstructured":"LaFave, L.M. & Levine, R.L. JAK2 the future: therapeutic strategies for JAK-dependent malignancies. Trends Pharmacol. Sci. 33, 574\u2013582 (2012).","journal-title":"Trends Pharmacol. Sci."},{"key":"BFnm3770_CR26","doi-asserted-by":"publisher","first-page":"4031","DOI":"10.1182\/blood.V90.10.4031","volume":"90","author":"Y Horikawa","year":"1997","unstructured":"Horikawa, Y. et al. Markedly reduced expression of platelet c-mpl receptor in essential thrombocythemia. Blood 90, 4031\u20134038 (1997).","journal-title":"Blood"},{"key":"BFnm3770_CR27","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1056\/NEJM199802263380903","volume":"338","author":"AR Moliterno","year":"1998","unstructured":"Moliterno, A.R., Hankins, W.D. & Spivak, J.L. Impaired expression of the thrombopoietin receptor by platelets from patients with polycythemia vera. N. Engl. J. Med. 338, 572\u2013580 (1998).","journal-title":"N. Engl. J. Med."},{"key":"BFnm3770_CR28","doi-asserted-by":"publisher","first-page":"2859","DOI":"10.1182\/blood.V93.9.2859","volume":"93","author":"K Cohen-Solal","year":"1999","unstructured":"Cohen-Solal, K., Vitrat, N., Titeux, M., Vainchenker, W. & Wendling, F. High-level expression of Mpl in platelets and megakaryocytes is independent of thrombopoietin. Blood 93, 2859\u20132866 (1999).","journal-title":"Blood"},{"key":"BFnm3770_CR29","first-page":"244","volume":"93","author":"S Karpatkin","year":"1980","unstructured":"Karpatkin, S. & Shulman, S. Asialo platelets enhance thrombopoiesis. Trans. Assoc. Am. Physicians 93, 244\u2013250 (1980).","journal-title":"Trans. Assoc. Am. Physicians"},{"key":"BFnm3770_CR30","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.1016\/j.cell.2007.01.037","volume":"128","author":"KD Mason","year":"2007","unstructured":"Mason, K.D. et al. Programmed anuclear cell death delimits platelet life span. Cell 128, 1173\u20131186 (2007).","journal-title":"Cell"},{"key":"BFnm3770_CR31","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.1084\/jem.20110750","volume":"208","author":"EC Josefsson","year":"2011","unstructured":"Josefsson, E.C. et al. Megakaryocytes possess a functional intrinsic apoptosis pathway that must be restrained to survive and produce platelets. J. Exp. Med. 208, 2017\u20132031 (2011).","journal-title":"J. Exp. Med."},{"key":"BFnm3770_CR32","doi-asserted-by":"publisher","first-page":"5850","DOI":"10.1182\/blood-2011-12-398834","volume":"119","author":"MA Debrincat","year":"2012","unstructured":"Debrincat, M.A. et al. Mcl-1 and Bcl-xL co-ordinately regulate megakaryocyte survival. Blood 119, 5850\u20135858 (2012).","journal-title":"Blood"},{"key":"BFnm3770_CR33","doi-asserted-by":"publisher","first-page":"943","DOI":"10.1038\/sj.cdd.4402081","volume":"14","author":"H Zhang","year":"2007","unstructured":"Zhang, H. et al. Bcl-2 family proteins are essential for platelet survival. Cell Death Differ. 14, 943\u2013951 (2007).","journal-title":"Cell Death Differ."},{"key":"BFnm3770_CR34","doi-asserted-by":"publisher","first-page":"e101","DOI":"10.1182\/blood-2011-03-339705","volume":"118","author":"JW Rowley","year":"2011","unstructured":"Rowley, J.W. et al. Genome-wide RNA-seq analysis of human and mouse platelet transcriptomes. Blood 118, e101\u2013e111 (2011).","journal-title":"Blood"},{"key":"BFnm3770_CR35","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.4161\/cc.10.10.15619","volume":"10","author":"CA de Graaf","year":"2011","unstructured":"de Graaf, C.A. & Metcalf, D. Thrombopoietin and hematopoietic stem cells. Cell Cycle 10, 1582\u20131589 (2011).","journal-title":"Cell Cycle"},{"key":"BFnm3770_CR36","doi-asserted-by":"publisher","first-page":"5884","DOI":"10.1073\/pnas.1404354111","volume":"111","author":"AP Ng","year":"2014","unstructured":"Ng, A.P. et al. Mpl expression on megakaryocytes and platelets is dispensable for thrombopoiesis but essential to prevent myeloproliferation. Proc. Natl. Acad. Sci. USA 111, 5884\u20135889 (2014).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"BFnm3770_CR37","doi-asserted-by":"publisher","first-page":"390","DOI":"10.2307\/3580223","volume":"152","author":"MA Mouthon","year":"1999","unstructured":"Mouthon, M.A., Vandamme, M., Gourmelon, P., Vainchenker, W. & Wendling, F. Preferential liver irradiation enhances hematopoiesis through a thrombopoietin-independent mechanism. Radiat. Res. 152, 390\u2013397 (1999).","journal-title":"Radiat. Res."},{"key":"BFnm3770_CR38","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1046\/j.1365-2141.1996.d01-1702.x","volume":"93","author":"S Kosugi","year":"1996","unstructured":"Kosugi, S. et al. Circulating thrombopoietin level in chronic immune thrombocytopenic purpura. Br. J. Haematol. 93, 704\u2013706 (1996).","journal-title":"Br. J. Haematol."},{"key":"BFnm3770_CR39","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1055\/s-0038-1650545","volume":"76","author":"N Ichikawa","year":"1996","unstructured":"Ichikawa, N. et al. Regulation of serum thrombopoietin levels by platelets and megakaryocytes in patients with aplastic anaemia and idiopathic thrombocytopenic purpura. Thromb. Haemost. 76, 156\u2013160 (1996).","journal-title":"Thromb. Haemost."},{"key":"BFnm3770_CR40","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1097\/00001721-199709000-00004","volume":"8","author":"K Hiyoyama","year":"1997","unstructured":"Hiyoyama, K. et al. Increased serum levels of thrombopoietin in patients with thrombotic thrombocytopenic purpura, idiopathic thrombocytopenic purpura, or disseminated intravascular coagulation. Blood Coagul. Fibrinolysis 8, 345\u2013349 (1997).","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"BFnm3770_CR41","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0002-9343(98)00090-4","volume":"104","author":"JC Wang","year":"1998","unstructured":"Wang, J.C. et al. Blood thrombopoietin levels in clonal thrombocytosis and reactive thrombocytosis. Am. J. Med. 104, 451\u2013455 (1998).","journal-title":"Am. J. Med."},{"key":"BFnm3770_CR42","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s002770050445","volume":"77","author":"M Griesshammer","year":"1998","unstructured":"Griesshammer, M. et al. High levels of thrombopoietin in sera of patients with essential thrombocythemia: cause or consequence of abnormal platelet production? Ann. Hematol. 77, 211\u2013215 (1998).","journal-title":"Ann. Hematol."},{"key":"BFnm3770_CR43","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1016\/0092-8674(95)90531-6","volume":"81","author":"RA Shivdasani","year":"1995","unstructured":"Shivdasani, R.A. et al. Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin\/MGDF in megakaryocyte development. Cell 81, 695\u2013704 (1995).","journal-title":"Cell"},{"key":"BFnm3770_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.ejcb.2011.09.010","volume":"91","author":"R Eulenfeld","year":"2012","unstructured":"Eulenfeld, R. et al. Interleukin-6 signalling: more than Jaks and STATs. Eur. J. Cell Biol. 91, 486\u2013495 (2012).","journal-title":"Eur. J. Cell Biol."},{"key":"BFnm3770_CR45","doi-asserted-by":"crossref","first-page":"26626","DOI":"10.1016\/S0021-9258(18)47064-0","volume":"269","author":"RJ Fallon","year":"1994","unstructured":"Fallon, R.J., Danaher, M. & Saxena, A. The asialoglycoprotein receptor is associated with a tyrosine kinase in HepG2 cells. J. Biol. Chem. 269, 26626\u201326629 (1994).","journal-title":"J. Biol. Chem."},{"key":"BFnm3770_CR46","doi-asserted-by":"publisher","first-page":"e59675","DOI":"10.1371\/journal.pone.0059675","volume":"8","author":"SO Park","year":"2013","unstructured":"Park, S.O. et al. Conditional deletion of Jak2 reveals an essential role in hematopoiesis throughout mouse ontogeny: implications for Jak2 inhibition in humans. PLoS ONE 8, e59675 (2013).","journal-title":"PLoS ONE"},{"key":"BFnm3770_CR47","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.3324\/haematol.2013.100016","volume":"99","author":"J Grisouard","year":"2014","unstructured":"Grisouard, J., Hao-Shen, H., Dirnhofer, S., Wagner, K.U. & Skoda, R.C. Selective deletion of Jak2 in adult mouse hematopoietic cells leads to lethal anemia and thrombocytopenia. Haematologica 99, e52\u2013e54 (2014).","journal-title":"Haematologica"},{"key":"BFnm3770_CR48","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1182\/blood-2011-05-355628","volume":"119","author":"AJ Jansen","year":"2012","unstructured":"Jansen, A.J. et al. Desialylation accelerates platelet clearance following refrigeration and initiates GPIb\u03b1 metalloproteinase-mediated cleavage in mice. Blood 119, 1263\u20131273 (2012).","journal-title":"Blood"},{"key":"BFnm3770_CR49","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0092-8674(02)01253-9","volume":"112","author":"KM Hoffmeister","year":"2003","unstructured":"Hoffmeister, K.M. et al. The clearance mechanism of chilled blood platelets. Cell 112, 87\u201397 (2003).","journal-title":"Cell"},{"key":"BFnm3770_CR50","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1210\/en.2008-0938","volume":"150","author":"R Grozovsky","year":"2009","unstructured":"Grozovsky, R. et al. Type 2 deiodinase expression is induced by peroxisomal proliferator-activated receptor-\u03b3 agonists in skeletal myocytes. Endocrinology 150, 1976\u20131983 (2009).","journal-title":"Endocrinology"},{"key":"BFnm3770_CR51","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1182\/blood-2003-04-1305","volume":"102","author":"W Bergmeier","year":"2003","unstructured":"Bergmeier, W. et al. Metalloproteinase inhibitors improve the recovery and hemostatic function of in vitro\u2013aged or \u2013injured mouse platelets. Blood 102, 4229\u20134235 (2003).","journal-title":"Blood"},{"key":"BFnm3770_CR52","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1182\/blood-2011-04-348482","volume":"118","author":"A Jurak Begonja","year":"2011","unstructured":"Jurak Begonja, A., Hoffmeister, K., Hartwig, J. & Falet, H. FlnA-null megakaryocytes prematurely release large and fragile platelets that circulate poorly. Blood 118, 2285\u20132295 (2011).","journal-title":"Blood"}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm.3770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3770","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm.3770.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T18:49:00Z","timestamp":1684435740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm.3770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,8]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["BFnm3770"],"URL":"https:\/\/doi.org\/10.1038\/nm.3770","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725267774.793502147","asserted-by":"object"}]},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,8]]},"assertion":[{"value":"25 February 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}